January 8, 2021 07:10 AM ESTUpdated 10:56 AM

Covid-19 roundup: Pfizer, BioNTech study suggest vaccine works against variants; Researchers say Sinovac's vaccine is 78% effective

Nicole DeFeudis

Editor

Max Gelman

Senior Editor

Amid heightened concerns about new, largely unknown variants of SARS-CoV-2 that appear to spread more rapidly, Pfizer and BioNTech say they have preliminary evidence that …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

Covid-19 roundup: Pfizer, BioNTech study suggest vaccine works against variants; Researchers say Sinovac's vaccine is 78% effective

Nicole DeFeudis

Editor

Max Gelman

Senior Editor

Sign up to read this article for free.

Trump taps Johns Hopkins researcher Marty Makary to lead the FDA; also names CDC, surgeon general picks

FDA approves BridgeBio's heart disease drug, setting up competition with Pfizer, Alnylam

ADC biotech Adcendo nabs $135M Series B as it enters the clinic

Drug or biologic? An Eli Lilly lawsuit could impact weight loss drug compounders

For CDC, Trump picks Dave Weldon, a former congressman who pushed for vaccine injury claims

From vaccines to psychedelics, five drugmakers on what could change under a Trump administration

Covid-19 roundup: Pfiz­er, BioN­Tech study sug­gest vac­cine works against vari­ants; Re­searchers say Sino­vac's vac­cine is 78% ef­fec­tive

Editor

Senior Editor

Sign up to read this article for free.

more like this

Covid-19 roundup: Pfizer, BioNTech study suggest vaccine works against variants; Researchers say Sinovac's vaccine is 78% effective